Position in INCY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$3,290,500
+$274,237 QoQ
Shares Held
29,027
-9.4% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#269
of 834 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $117,820,260 across 121 Biotechnology names. INCY ranks #6 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
45,980 | $22,839,645 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,063 | $11,263,003 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
30,242 | $9,103,749 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
40,460 | $7,577,348 | |
| 5 | INSM |
INSMED Inc
|
48,273 | $5,146,867 | |
| 6 | INCY |
Incyte Corp
This page
|
29,027 | $3,290,500 | |
| 7 | RPRX |
Royalty Pharma plc
|
55,752 | $3,126,014 | |
| 8 | MRNA |
Moderna, Inc.
|
39,368 | $2,756,941 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,290,500 | 29,027 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $3,016,263 | 32,047 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,762,794 | 27,972 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,208,113 | 26,036 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,834,205 | 26,934 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,394,466 | 23,030 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $1,584,396 | 22,939 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,530,082 | 23,148 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,588,183 | 26,199 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,171,012 | 38,108 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,276,388 | 36,254 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $2,286,305 | 39,576 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $2,422,085 | 38,909 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $2,891,016 | 40,003 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $3,128,142 | 38,946 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $2,392,109 | 35,896 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $2,520,532 | 33,178 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $2,253,383 | 28,373 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $2,051,309 | 27,947 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $1,784,428 | 25,944 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $2,238,446 | 26,607 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,212,331 | 27,222 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $2,351,069 | 27,030 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,375,687 | 26,473 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $2,720,894 | 26,170 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||